Decibel Therapeutics, Inc.
DBTXDelisted Sep 25, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001656536
Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.
Holders of 5% or more of DBTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Decibel Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Decibel Therapeutics, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Decibel Therapeutics, Inc., newest first.
No Schedule 13D or 13G filings on Decibel Therapeutics, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Decibel Therapeutics, Inc. shares.
No Form 144 notices for Decibel Therapeutics, Inc. are on file.